Nursing care
Typical vs atypical antipsychotics: movement effects, metabolic effects and monitoring
Written and reviewed by Dana Whitfield, RN, MSN · 4 min read · Updated October 2026
Short answer
First-generation or typical antipsychotics, such as haloperidol, carry a higher risk of movement effects: acute dystonia, akathisia, drug-induced parkinsonism and tardive dyskinesia. Second-generation or atypical agents, such as olanzapine and risperidone, have lower movement risk but more metabolic effects: weight gain, raised glucose and lipids. Both groups need monitoring, and serious reactions can occur with either.
The headline trade-off: movement versus metabolism
MSD summarises the practical difference: second-generation agents are less likely to cause involuntary movement disorders, while metabolic problems such as abdominal weight gain, insulin resistance, dyslipidaemia and hypertension are more common with them. That trade-off drives most exam items. A question about a stiff, shuffling patient on haloperidol is about extrapyramidal effects; one about rising weight and glucose on olanzapine is about metabolic effects.
These are tendencies, not rules. Atypical agents can still cause movement effects, particularly at higher doses, and some typical agents affect weight. Clozapine is an atypical drug reserved for treatment-resistant illness and carries its own requirement for regular blood tests because of a rare but dangerous fall in white cells.
Recognising extrapyramidal effects
Acute dystonia is a sudden, sustained muscle spasm, such as neck twisting, eyes rolling upward or jaw clenching, often early in treatment; spasm affecting the throat is an emergency because it can threaten the airway. Akathisia is inner restlessness with pacing and an inability to sit still, easily mistaken for worsening agitation. Parkinsonism brings tremor, rigidity and a shuffling gait.
Tardive dyskinesia develops after longer exposure and causes repetitive involuntary movements, often of the lips, tongue and face. NIMH highlights it as a risk of long-term typical antipsychotic use. Screening for abnormal movements at intervals is part of nursing care, and new movements are reported rather than dismissed as habits.
Recognising metabolic and other effects
NIMH notes that people taking atypical antipsychotics need regular monitoring of weight, glucose and lipids. Nurses record baseline and follow-up weight, waist measurement and blood pressure, watch for thirst and frequent urination suggesting high glucose, and support diet and activity changes alongside the prescribed plan.
Some agents in both groups can prolong the QT interval, so ask about palpitations or fainting and know whether an ECG is part of monitoring. Sedation, orthostatic hypotension and anticholinergic effects such as dry mouth and constipation occur across the classes. Neuroleptic malignant syndrome, with fever, severe rigidity and altered consciousness, is rare but can occur with either generation and needs urgent escalation.
Teaching for each generation
For a patient starting a typical agent, teach which movement symptoms to report promptly, such as muscle spasms, restlessness or stiffness, and why regular movement checks happen. Explain that treatments exist for some effects and that the prescriber may adjust therapy. Advise rising slowly to reduce dizziness.
For a patient starting an atypical agent, teach that weight, blood sugar and cholesterol checks are part of safe treatment, not a sign that something has gone wrong. Encourage reporting increased thirst, appetite changes and rapid weight gain early. For both, stress not stopping suddenly without speaking to the prescriber and reporting high fever with rigidity immediately.
Worked study scenario
Imagine a hypothetical patient who started haloperidol yesterday and now has the head pulled to one side, eyes fixed upward and difficulty swallowing. Options include documenting expected adjustment, encouraging the patient to relax, or assessing the airway and notifying the prescriber for urgent treatment of acute dystonia. The third option is strongest.
Recent typical antipsychotic exposure plus sudden sustained spasm fits acute dystonia, and swallowing difficulty raises airway concern. Calling it adjustment ignores a treatable reaction. If the same patient instead had six months of olanzapine and a large weight gain, the priority would shift to metabolic monitoring and teaching rather than emergency care.
Sources and further reading
NIMH: Mental health medications. First and second generation antipsychotics, tardive dyskinesia with typical agents, weight, glucose and lipid monitoring, clozapine blood tests.
MSD Manual Professional: Schizophrenia. Lower movement-disorder risk and higher metabolic risk with second generation agents, dystonia, akathisia, parkinsonism, QT prolongation, clozapine use.
The next step on this is the same as on everything else here: answer questions and read the rationales. Our pharmacology practice questions are the closest set to what this page covers.
One question from the pharmacology set
A client with heart failure is started on furosemide 40 mg PO daily. Which findings should the nurse report to the provider before administering the next dose? Select all that apply.
Rationale
Furosemide is a loop diuretic, so the two things you are watching are potassium and kidney function. A potassium of 2.9 mEq/L is below the 3.5–5.0 reference range and puts the client at risk for dysrhythmia — hold and report. Muscle cramps with palpitations are the clinical face of that same hypokalemia, so they are reported together, not separately. A creatinine that doubles signals the diuresis has outrun renal perfusion. A blood pressure of 132/78 and a 1 kg loss are the expected response to the drug working, not reasons to hold it.
Answer: A, D, E
Common questions
Do atypical antipsychotics cause tardive dyskinesia?
They carry a lower risk than typical agents but can still cause it. Movement screening continues for patients on any antipsychotic, especially with long-term use.
Which labs matter most for atypical antipsychotics?
Glucose and lipids, along with weight, waist and blood pressure. NIMH notes regular monitoring of weight, glucose and lipid levels for people taking atypical agents. Clozapine also needs regular blood counts.
How is akathisia different from agitation?
Akathisia is a drug-induced sense of inner restlessness that makes the person pace or shift constantly. It can look like worsening agitation, so ask how the restlessness feels and report it rather than assuming the illness is worse.
More on pharmacology
Guides on this